Fingerprint
Dive into the research topics of 'Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
Stephen Johnston, Joyce O’Shaughnessy, Miguel Martin, Jens Huober, Masakazu Toi, Joohyuk Sohn, Valérie A.M. André, Holly R. Martin, Molly C. Hardebeck, Matthew P. Goetz
Research output: Contribution to journal › Article › peer-review